Next Article in Journal
Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
Previous Article in Journal
Cannabinoids, Blood–Brain Barrier, and Brain Disposition
Previous Article in Special Issue
A 3D Bioprinted Pseudo-Bone Drug Delivery Scaffold for Bone Tissue Engineering
Open AccessEditorial

3D Printing of Pharmaceuticals and Drug Delivery Devices

1
School of Pharmacy, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
2
Department of Life and Environmental Sciences (Unit of Drug Sciences), University of Cagliari, 09124 Cagliari, Italy
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(3), 266; https://doi.org/10.3390/pharmaceutics12030266
Received: 12 March 2020 / Accepted: 13 March 2020 / Published: 15 March 2020
(This article belongs to the Special Issue 3D Printing of Pharmaceuticals and Drug Delivery Devices)
The process of 3D printing (3DP) was patented in 1986; however, the research in the field of 3DP did not become popular until the last decade. There has been an increasing research into the areas of 3DP for medical applications for fabricating prosthetics, bioprinting and pharmaceutics. This novel method allows the manufacture of dosage forms on demand, with modifications in the geometry and size resulting in changes to the release and dosage behaviour of the product. 3DP will allow wider adoption of personalised medicine due to the diversity and simplicity to change the design and dosage of the products, allowing the devices to be designed specific to the individual with the ability to alternate the drugs added to the product. Personalisation also has the potential to decrease the common side effects associated with generic dosage forms. This Special Issue Editorial outlines the current innovative research surrounding the topic of 3DP, focusing on bioprinting and various types of 3DP on applications for drug delivery as well advantages and future directions in this field of research. View Full-Text
Keywords: 3D printing; bioprinting; additive manufacturing; computer-aided design (CAD); drug delivery; personalized medicine; pharmaceutics 3D printing; bioprinting; additive manufacturing; computer-aided design (CAD); drug delivery; personalized medicine; pharmaceutics
MDPI and ACS Style

Mathew, E.; Pitzanti, G.; Larrañeta, E.; Lamprou, D.A. 3D Printing of Pharmaceuticals and Drug Delivery Devices. Pharmaceutics 2020, 12, 266.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop